Clinical Practice Guidelines
Clinical Practice Guidelines recommend BIS for Lymphedema Screening
Prevent Breast Cancer-Related Lymphedema with Early Detection
The SOZO Digital Health Platform is the only FDA-cleared bioimpedance spectroscopy (BIS) solution for the clinical assessment of lymphedema. BIS is the most advanced method of using bioimpedance measurements to assess fluid levels and tissue composition.
Now Available!
SOZO Software Version 6.0.0
Improve Program & Patient Management across the Care Continuum.
Quick & Simple Test
A SOZO test is fast and may be performed by any member of the care team. Results are instantly available at the point of care and through the MySOZO web‑based portal, and may be integrated with your EHR for auto-documentation.
Early & Accurate Detection
Our patented bioimpedance spectroscopy (BIS) technology can detect lymphedema as early as the subclinical stage (stage 0) before noticeable swelling, allowing for early intervention to stop progression to chronic lymphedema1.
The L-Dex® score, utilizing BIS, provides an accurate and quick output of lymphedema-related fluid changes in the limbs, supporting consistent monitoring for your lymphedema screening standard of care.
Clinical Evidence
PREVENT is the Largest Randomized Clinical Trial to Assess Lymphedema Prevention
Lymphedema Prospective Surveillance Model
Motivate patients to comply with treatment. ImpediMed’s Lymphedema Prevention Program (LPP) is an Evidence-Based Protocol for Optimal Patient Outcomes
National Comprehensive Cancer Network® (NCCN®)
Unlock Powerful Patient Data for Coordinated Care
With L-Dex Analytics, access patient trending data at the point of care and across care teams for comprehensive lymphedema surveillance.
Secure Patient Data
 |
Private
|
 |
Connected
|
Improve Patient Access to Lymphedema Care
ImpediMed partners with you to implement a lymphedema prospective surveillance model that supports your existing patient workflow.
- SOZO’s BIS testing has a Category 1 CPT code (93702) and is covered by Medicare and a growing number of national private payors
- ImpediMed provides complimentary reimbursement support to improve patient access to testing
Software Specifications
| SOZOapp: | Android 8.1 or greater / iOS v13 or greater |
| MySOZO: | Chrome or Edge Chromium or Firefox browser |
| SOZO Outputs: | L-Dex® lymphedema index, HF-Dex® heart failure index, Total body water, Extracellular fluid, Intracellular fluid, Hy-Dex® hydration analysis Skeletal muscle mass, Fat mass, Fat-free Mass, Protein and minerals, Basal metabolic rate, Phase angle, Body mass index, Weight, Segmental outputs |
Hardware Specifications
| Tablet: | Samsung Galaxy Tab A / iPad |
| Weight Capacity: | Standing: 375lb / 170 kg, Sitting: 750 lb / 340 kg |
| Weight: | SOZO Device: 10.0 lb / 4.5 kg, SOZOsupport Stand: 25.5 lb / 11.6 kg |
| Dimensions: | 51.1 x 17.5 x 25.5 in / 129.8 x 44.5 x 64.8 cm |
| Sensors: | 8 stainless steel electrodes |
| Frequency Scan: | 3 to 1000 kHz (256 frequencies) |
| Measurement Speed: | Less than 30 seconds1 |
References
- Ridner SH, et al. A Comparison of Bioimpedance Spectroscopy or Tape Measure Triggered Compression Intervention in Chronic Breast Cancer Lymphedema Prevention. Lymphatic Research and Biology 2022.
- Referenced with permission from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Survivorship V.1.2023. © National Comprehensive Cancer Network, Inc. 2023. All rights reserved. Accessed March 23, 2023. To view the most recent and complete version of the guideline, go online to NCCN.org. NCCN makes no warranties of any kind whatsoever regarding their content, use or application and disclaims any responsibility for their application or use in any way.